What are the classifications of thalassemia?

Classifications of Thalassemia

Thalassemia is classified into two main genetic types (α-thalassemia and β-thalassemia) and further subdivided by clinical severity into major, intermedia, and minor forms, with a modern functional classification based on transfusion dependency that better guides clinical management.

Primary Genetic Classification

Thalassemia fundamentally divides into two categories based on which globin chain is affected:

• α-Thalassemia: Results from defects in α-globin chain production, occurring primarily in individuals of Southeast Asian descent 1
• β-Thalassemia: Caused by severe reduction or absent production of β-globin chains, most prevalent in areas with endemic malaria exposure including Asia, the Middle East, and Mediterranean Europe 1

Traditional Clinical Severity Classification

The historical classification system categorizes thalassemia by phenotypic severity 2, 3:

β-Thalassemia Subtypes

• β-Thalassemia Major (TM): Life-threatening anemia beginning at 1-2 years of age requiring lifelong transfusions, characterized by >8 transfusion events per year in adults >16 years 1
• β-Thalassemia Intermedia: Variable presentation with generally no transfusion requirement to maintain hemoglobin, though transfusions may become necessary with age to prevent cardiovascular and other complications 1
• β-Thalassemia Minor (Trait): Asymptomatic carrier state 4

α-Thalassemia Subtypes

• α-Thalassemia Major: Severe hemolytic anemia typically leading to hydrops fetalis and fetal demise, often fatal at birth 1, 4
• HbH Disease: Part of the α-thalassemia spectrum with variable severity 1, 5
• α-Thalassemia Minor (Trait): Asymptomatic carrier state 4

Modern Functional Classification

The current preferred classification system is based on transfusion dependency rather than traditional nomenclature 2, 3:

Transfusion-Dependent Thalassemia (TDT)

Includes patients requiring regular blood transfusions to survive, encompassing 3:

• β-Thalassemia major
• Transfusion-dependent α-thalassemia HbH disease
• Some cases of E-β-thalassemia
• Combined α- and β-thalassemias requiring transfusions

Non-Transfusion-Dependent Thalassemia (NTDT)

Includes patients who do not require regular transfusions to maintain hemoglobin levels, encompassing 1, 3:

• β-Thalassemia intermedia
• Non-transfusion-dependent α-thalassemia HbH disease
• Some patients with E-β-thalassemia
• Combined α- and β-thalassemias not requiring regular transfusions

Important Clinical Distinctions

This classification is dynamic—patients may progress from NTDT to TDT over time 2, 3. The functional classification has practical advantages because it:

• Guides iron chelation therapy requirements (both TDT and NTDT can develop iron overload, though mechanisms differ) 1
• Predicts complication patterns: NTDT shows greater propensity for pulmonary hypertension and thrombosis, while TDT primarily faces iron overload complications 1
• Determines screening protocols for endocrine complications (TDT requires screening before age 10 years; NTDT from age 11 years onward) 5

Genotype-Based Variants

Additional classification by specific genotypes includes 1:

• HbSS, HbSC, Sβ⁰-thalassemia, Sβ⁺-thalassemia: Sickle cell disease variants (distinct from pure thalassemia but relevant for differential diagnosis)
• E-β-thalassemia: Common variant with variable severity 1, 3
• Rare variants: Including combinations with hemoglobin D-Punjab, E, or O-Arab 1

Diagnostic Approach

Mean corpuscular volume (MCV) <80 fL in both parents suggests thalassemia carrier status and warrants further genetic testing 1. Definitive diagnosis requires hemoglobin electrophoresis and molecular genetic studies to identify specific globin gene mutations 2, 3.